GAM Systematic’s Eli Lilly LLY Stock Holding History

GAM Systematic’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$926K	Buy	10,828 +5,875	+119%	+$482K	0.13%	301
2017 Q2	$408K	Buy	+4,953	New	+$404K	0.06%	443
2016 Q4	–	Sell	-1,164	Closed	-$93K	–	645
2016 Q3	$93K	Buy	+1,164	New	+$93.2K	0.02%	554
2016 Q2	–	Sell	-7,172	Closed	-$516K	–	662
2016 Q1	$516K	Sell	7,172 -5,921	-45%	-$448K	0.14%	304
2015 Q4	$1.1M	Sell	13,093 -6,814	-34%	-$565K	0.31%	79
2015 Q3	$1.67M	Sell	19,907 -29,375	-60%	-$2.48M	0.39%	38
2015 Q2	$4.12M	Sell	49,282 -72,224	-59%	-$5.5M	0.52%	49
2015 Q1	$8.83M	Buy	121,506 +27,852	+30%	+$1.98M	1.22%	1
2014 Q4	$6.46M	Buy	+93,654	New	+$6.32M	1.31%	1

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

GAM Systematic's LLY Position: Q3 2017 in Review

GAM Systematic increased its Eli Lilly (LLY) stake by 119% in Q3 2017, buying an estimated $482K and bringing the position to 10,828 shares worth $926K. The position accounts for 0.13% of the portfolio, ranked #301.

GAM Systematic first reported a position in LLY in Q4 2014 and has held it in 9 quarters since. The position peaked at $8.83M in Q1 2015. 1,228 funds tracked by Wall St. Rank hold LLY as of Q3 2017.

GAM Systematic held 10,828 shares of Eli Lilly worth $926K as of Q3 2017.
GAM Systematic bought 5,875 Eli Lilly shares in Q3 2017, an estimated $482K.
Eli Lilly made up 0.13% of GAM Systematic's portfolio in Q3 2017, its #301 holding.
GAM Systematic first reported a position in Eli Lilly in Q4 2014 and has held it in 9 quarters since.
GAM Systematic's Eli Lilly position peaked at $8.83M in Q1 2015.
1,228 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.